Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2023 | 506 | 0.680 |
Why?
|
Bacteriological Techniques | 1 | 2020 | 275 | 0.640 |
Why?
|
Influenza, Human | 4 | 2022 | 1521 | 0.570 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 426 | 0.530 |
Why?
|
Influenza Vaccines | 2 | 2022 | 767 | 0.530 |
Why?
|
Carrier State | 1 | 2019 | 522 | 0.500 |
Why?
|
Appendectomy | 1 | 2019 | 434 | 0.490 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3093 | 0.460 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3215 | 0.460 |
Why?
|
Staphylococcal Infections | 2 | 2020 | 1401 | 0.440 |
Why?
|
Bacteremia | 1 | 2020 | 978 | 0.430 |
Why?
|
Hospitalization | 5 | 2022 | 10707 | 0.410 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 696 | 0.410 |
Why?
|
Appendicitis | 1 | 2019 | 676 | 0.390 |
Why?
|
Antiviral Agents | 3 | 2021 | 3048 | 0.390 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2023 | 2421 | 0.370 |
Why?
|
Influenza A Virus, H1N1 Subtype | 2 | 2021 | 447 | 0.270 |
Why?
|
Long-Term Care | 2 | 2020 | 630 | 0.260 |
Why?
|
Rhode Island | 6 | 2021 | 351 | 0.250 |
Why?
|
Prevalence | 7 | 2024 | 15721 | 0.240 |
Why?
|
Hepatitis A virus | 1 | 2023 | 16 | 0.220 |
Why?
|
Obesity | 3 | 2020 | 12940 | 0.220 |
Why?
|
Hepatitis A | 1 | 2023 | 127 | 0.210 |
Why?
|
Hepatitis E virus | 1 | 2023 | 72 | 0.200 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15841 | 0.200 |
Why?
|
Hepatitis E | 1 | 2023 | 76 | 0.200 |
Why?
|
Nutrition Surveys | 3 | 2024 | 1723 | 0.200 |
Why?
|
Herpes Zoster Vaccine | 1 | 2022 | 49 | 0.200 |
Why?
|
Opportunistic Infections | 1 | 2023 | 376 | 0.180 |
Why?
|
Hidradenitis Suppurativa | 1 | 2023 | 177 | 0.170 |
Why?
|
Influenza B virus | 1 | 2020 | 50 | 0.170 |
Why?
|
Influenza A Virus, H3N2 Subtype | 1 | 2020 | 83 | 0.170 |
Why?
|
Burns, Inhalation | 1 | 2019 | 35 | 0.160 |
Why?
|
Octreotide | 1 | 2020 | 154 | 0.160 |
Why?
|
Respiration, Artificial | 2 | 2021 | 2631 | 0.160 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 137 | 0.160 |
Why?
|
Azithromycin | 1 | 2020 | 199 | 0.160 |
Why?
|
Klebsiella Infections | 1 | 2020 | 144 | 0.160 |
Why?
|
Burn Units | 1 | 2019 | 143 | 0.160 |
Why?
|
Liver Neoplasms | 2 | 2024 | 4310 | 0.150 |
Why?
|
Liver Cirrhosis | 3 | 2024 | 1932 | 0.150 |
Why?
|
Somatostatin | 1 | 2020 | 447 | 0.150 |
Why?
|
Fires | 1 | 2019 | 171 | 0.150 |
Why?
|
Metabolic Diseases | 1 | 2024 | 680 | 0.150 |
Why?
|
Intestinal Neoplasms | 1 | 2020 | 315 | 0.150 |
Why?
|
False Positive Reactions | 1 | 2020 | 958 | 0.150 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2020 | 342 | 0.140 |
Why?
|
Fast Foods | 1 | 2019 | 210 | 0.140 |
Why?
|
Fatty Liver | 1 | 2023 | 789 | 0.140 |
Why?
|
Asymptomatic Diseases | 1 | 2020 | 588 | 0.140 |
Why?
|
Anti-Bacterial Agents | 3 | 2020 | 7407 | 0.140 |
Why?
|
HIV Infections | 1 | 2023 | 17348 | 0.130 |
Why?
|
Intensive Care Units | 2 | 2020 | 3744 | 0.130 |
Why?
|
Escherichia coli Infections | 1 | 2020 | 518 | 0.130 |
Why?
|
Humans | 30 | 2024 | 761222 | 0.130 |
Why?
|
Dementia | 2 | 2020 | 2684 | 0.130 |
Why?
|
Pseudomonas Infections | 1 | 2020 | 621 | 0.130 |
Why?
|
Demography | 1 | 2020 | 1641 | 0.120 |
Why?
|
Neutropenia | 1 | 2020 | 885 | 0.120 |
Why?
|
Biological Products | 1 | 2023 | 915 | 0.120 |
Why?
|
Clinical Protocols | 1 | 2020 | 1436 | 0.120 |
Why?
|
Seasons | 1 | 2020 | 1518 | 0.110 |
Why?
|
Neuroendocrine Tumors | 1 | 2020 | 642 | 0.110 |
Why?
|
Radiography, Thoracic | 1 | 2020 | 1302 | 0.110 |
Why?
|
Informed Consent | 1 | 2020 | 1008 | 0.110 |
Why?
|
Pandemics | 4 | 2020 | 8663 | 0.110 |
Why?
|
Infection Control | 1 | 2020 | 983 | 0.110 |
Why?
|
Fever | 1 | 2020 | 1618 | 0.100 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2020 | 1520 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2024 | 2293 | 0.100 |
Why?
|
Comorbidity | 3 | 2022 | 10516 | 0.100 |
Why?
|
Adult | 10 | 2024 | 221120 | 0.100 |
Why?
|
Vaccination | 2 | 2022 | 3369 | 0.090 |
Why?
|
Inpatients | 1 | 2023 | 2545 | 0.090 |
Why?
|
Middle Aged | 9 | 2024 | 220858 | 0.090 |
Why?
|
Aged | 9 | 2024 | 169292 | 0.090 |
Why?
|
Hepatitis C | 1 | 2020 | 1579 | 0.090 |
Why?
|
Young Adult | 5 | 2024 | 59222 | 0.090 |
Why?
|
Stomach Neoplasms | 1 | 2020 | 1457 | 0.080 |
Why?
|
Pneumonia | 1 | 2021 | 2142 | 0.080 |
Why?
|
Residence Characteristics | 1 | 2019 | 2092 | 0.080 |
Why?
|
Hematologic Neoplasms | 1 | 2021 | 1895 | 0.080 |
Why?
|
Insurance Coverage | 1 | 2020 | 1935 | 0.080 |
Why?
|
Arthritis, Rheumatoid | 1 | 2024 | 3753 | 0.080 |
Why?
|
Retrospective Studies | 6 | 2023 | 80675 | 0.080 |
Why?
|
Male | 11 | 2024 | 360703 | 0.080 |
Why?
|
Acute Disease | 1 | 2019 | 7226 | 0.070 |
Why?
|
Risk Factors | 4 | 2024 | 74241 | 0.070 |
Why?
|
Odds Ratio | 1 | 2020 | 9652 | 0.070 |
Why?
|
Kidney Failure, Chronic | 1 | 2020 | 2478 | 0.070 |
Why?
|
Diabetes Mellitus | 2 | 2024 | 5842 | 0.070 |
Why?
|
Depressive Disorder | 1 | 2020 | 3727 | 0.070 |
Why?
|
Female | 11 | 2024 | 392552 | 0.070 |
Why?
|
Liver | 1 | 2023 | 7512 | 0.070 |
Why?
|
Prospective Studies | 2 | 2023 | 54437 | 0.070 |
Why?
|
Body Mass Index | 2 | 2021 | 12952 | 0.070 |
Why?
|
Patient Readmission | 1 | 2020 | 3265 | 0.070 |
Why?
|
Logistic Models | 1 | 2020 | 13249 | 0.060 |
Why?
|
Hepatitis A Antibodies | 1 | 2023 | 19 | 0.060 |
Why?
|
Asia | 1 | 2024 | 622 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5666 | 0.050 |
Why?
|
Hepatitis B Antibodies | 1 | 2023 | 155 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2020 | 5366 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2020 | 58952 | 0.050 |
Why?
|
United States | 3 | 2023 | 72341 | 0.040 |
Why?
|
Child, Hospitalized | 1 | 2022 | 182 | 0.040 |
Why?
|
Hepatitis B virus | 1 | 2023 | 527 | 0.040 |
Why?
|
Adenosine Monophosphate | 1 | 2021 | 231 | 0.040 |
Why?
|
Israel | 1 | 2021 | 718 | 0.040 |
Why?
|
Alanine | 1 | 2021 | 608 | 0.040 |
Why?
|
Adolescent | 3 | 2024 | 88300 | 0.040 |
Why?
|
Immunization | 1 | 2022 | 1218 | 0.040 |
Why?
|
Child | 3 | 2022 | 80154 | 0.040 |
Why?
|
Length of Stay | 2 | 2022 | 6417 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39127 | 0.040 |
Why?
|
Child, Preschool | 1 | 2020 | 42225 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20588 | 0.030 |
Why?
|
Influenza A virus | 1 | 2020 | 458 | 0.030 |
Why?
|
Neoplasms | 1 | 2024 | 22142 | 0.030 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 561 | 0.030 |
Why?
|
Europe | 1 | 2021 | 3423 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2023 | 1589 | 0.030 |
Why?
|
Incidence | 2 | 2024 | 21366 | 0.030 |
Why?
|
Psychometrics | 1 | 2020 | 3061 | 0.020 |
Why?
|
Cost of Illness | 1 | 2020 | 1936 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2020 | 2004 | 0.020 |
Why?
|
Myocardial Ischemia | 1 | 2020 | 2133 | 0.020 |
Why?
|
Critical Illness | 1 | 2021 | 2724 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5493 | 0.020 |
Why?
|
Health Care Costs | 1 | 2020 | 3239 | 0.020 |
Why?
|
Medicaid | 1 | 2020 | 2813 | 0.020 |
Why?
|
Computer Simulation | 1 | 2020 | 6224 | 0.020 |
Why?
|
Databases, Factual | 1 | 2020 | 7965 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2021 | 64681 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22174 | 0.010 |
Why?
|
Medicare | 1 | 2020 | 6774 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 13367 | 0.010 |
Why?
|
Infant | 1 | 2022 | 36170 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 26072 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 24022 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41496 | 0.010 |
Why?
|
Concepts
(141)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_